The Influence of Hydrosalpinx on Markers of Endometrial Receptivity

ABSTRACT

Hydrosalpinx is a common condition among women of reproductive age. It is related to low pregnancy rates in the settings of in vitro fertilization-embryo transfer programs. Such low rates are not yet well understood, and may be due to poor endometrial receptivity and abnormal expression of key molecules in the endometrium that are important for implantation. The available data on the inflammatory response, endometrial blood flow, integrins, leukemia inhibitory factor, matrix metalloproteinases, and homeobox gene A10 expression in the presence of hydrosalpinx are reviewed. In addition, the evidence for treatment options to improve pregnancy rates is also discussed.

Hydrosalpinx - endometrium

REFERENCES

• 1 Andersen A N, Yue Z, Meng F J, Petersen K. Low implantation rate after in-vitro fertilization in patients with hydrosalpinges diagnosed by ultrasonography.  Hum Reprod. 1994;  9 1935-1938
• 2 Katz E, Akman M A, Damewood M D, Garcia J E. Deleterious effect of the presence of hydrosalpinx on implantation and pregnancy rates with in vitro fertilization.  Fertil Steril. 1996;  66 122-125
• 3 Strandell A, Waldenstrom U, Nilsson L, Hamberger L. Hydrosalpinx reduces in-vitro fertilization/embryo transfer pregnancy rates.  Hum Reprod. 1994;  9 861-863
• 4 Blazar A S, Hogan J W, Seifer D B, Frishman G N, Wheeler C A, Haning R V. The impact of hydrosalpinx on successful pregnancy in tubal factor infertility treated by in vitro fertilization.  Fertil Steril. 1997;  67 517-520
• 5 Murray C A, Clarke H J, Tulandi T, Tan S L. Inhibitory effect of human hydrosalpingeal fluid on mouse preimplantation embryonic development is significantly reduced by the addition of lactate.  Hum Reprod. 1997;  12 2504-2507
• 6 Lass A. What effect does hydrosalpinx have on assisted reproduction? What is the preferred treatment for hydrosalpines? The ovary's perspective.  Hum Reprod. 1999;  14 1674-1677
• 7 Paik C K, Waetjen L E, Xing G, Dai J, Sweet R L. Hospitalizations for pelvic inflammatory disease and tuboovarian abscess.  Obstet Gynecol. 2006;  107 611-616
• 8 Mage G, Pouly J L, de Joliniere J B, Chabrand S, Riouallon A, Bruhat M A. A preoperative classification to predict the intrauterine and ectopic pregnancy rates after distal tubal microsurgery.  Fertil Steril. 1986;  46 807-810
• 9 The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, mullerian anomalies and intrauterine adhesions.  Fertil Steril. 1988;  49 944-955
• 10 Boer-Meisel M E, te Velde E R, Habbema J D, Kardaun J W. Predicting the pregnancy outcome in patients treated for hydrosalpinx: a prospective study.  Fertil Steril. 1986;  45 23-29
• 11 Rock J A, Katayama K P, Martin E J, Woodruff J D, Jones Jr H W. Factors influencing the success of salpingostomy techniques for distal fimbrial obstruction.  Obstet Gynecol. 1978;  52 591-596
• 12 Puttemans P, Brosens I, Delattin P, Vasquez G, Boeckx W. Salpingoscopy versus hysterosalpingography in hydrosalpinges.  Hum Reprod. 1987;  2 535-540
• 13 Donnez J, Casanas-Roux F. Prognostic factors of fimbrial microsurgery.  Fertil Steril. 1986;  46 200-204
• 14 Leese H J, Tay J I, Reischl J, Downing S J. Formation of Fallopian tubal fluid: role of a neglected epithelium.  Reproduction. 2001;  121 339-346
• 15 Tay J I, Rutherford A J, Killick S R, Maguiness S D, Partridge R J, Leese H J. Human tubal fluid: production, nutrient composition and response to adrenergic agents.  Hum Reprod. 1997;  12 2451-2456
• 16 The influence of hydrosalpinx on IVF and embryo transfer: a review.  Hum Reprod Update. 2000;  6 387-395
• 17 Seli E, Kayisli U A, Cakmak H et al.. Removal of hydrosalpinges increases endometrial leukaemia inhibitory factor (LIF) expression at the time of the implantation window.  Hum Reprod. 2005;  20 3012-3017
• 18 Gardner D K, Lane M, Calderon I, Leeton J. Environment of the preimplantation human embryo in vivo: metabolite analysis of oviduct and uterine fluids and metabolism of cumulus cells.  Fertil Steril. 1996;  65 349-353
• 19 Quinton P M. Cystic fibrosis: a disease in electrolyte transport.  FASEB J. 1990;  4 2709-2717
• 20 Quinton P M. Physiological basis of cystic fibrosis: a historical perspective.  Physiol Rev. 1999;  79 S3-S22
• 21 Ajonuma L C, Ng E H, Chow P H et al.. Increased cystic fibrosis transmembrane conductance regulator (CFTR) expression in the human hydrosalpinx.  Hum Reprod. 2005;  20 1228-1234
• 22 Arredondo J L, Diaz V, Gaitan H et al.. Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients.  Clin Infect Dis. 1997;  24 170-178
• 23 Ajonuma L C, Ng E H, Chan L N et al.. Ultrastructural characterization of whole hydrosalpinx from infertile Chinese women.  Cell Biol Int. 2005;  29 849-856
• 24 Ajonuma L C, Ng E H, Chan H C. New insights into the mechanisms underlying hydrosalpinx fluid formation and its adverse effect on IVF outcome.  Hum Reprod Update. 2002;  8 255-264
• 25 Gordon J D, Mesiano S, Zaloudek C J, Jaffe R B. Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation.  J Clin Endocrinol Metab. 1996;  81 353-359
• 26 Lam P M, Briton-Jones C, Cheung C K, Lok I H, Cheung L P, Haines C. In vivo regulation of mRNA expression of vascular endothelial growth factor receptors (KDR and flt-1) in the human oviduct.  Fertil Steril. 2004;  81 416-423
• 27 Lam P M, Briton-Jones C, Cheung C K, Po L S, Cheung L P, Haines C. Increased mRNA expression of vascular endothelial growth factor and its receptor (flt-1) in the hydrosalpinx.  Hum Reprod. 2003;  18 2264-2269
• 28 Mansour R T, Aboulghar M A, Serour G I, Riad R. Fluid accumulation of the uterine cavity before embryo transfer: a possible hindrance for implantation.  J In Vitro Fert Embryo Transf. 1991;  8 157-159
• 29 Eytan O, Azem F, Gull I, Wolman I, Elad D, Jaffa A J. The mechanism of hydrosalpinx in embryo implantation.  Hum Reprod. 2001;  16 2662-2667
• 30 Watermeyer S R, Bhal K. Chronic vaginal discharge secondary to a hydrosalpinx.  J Obstet Gynaecol. 2002;  22 324
• 31 Kiviat N B, Wolner-Hanssen P, Eschenbach D A et al.. Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis.  Am J Surg Pathol. 1990;  14 167-175
• 32 Ness R B, Soper D E, Holley R L et al.. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.  Am J Obstet Gynecol. 2002;  186 929-937
• 33 Korn A P, Hessol N A, Padian N S et al.. Risk factors for plasma cell endometritis among women with cervical Neisseria gonorrhoeae, cervical Chlamydia trachomatis, or bacterial vaginosis.  Am J Obstet Gynecol. 1998;  178 987-990
• 34 Achilles S L, Amortegui A J, Wiesenfeld H C. Endometrial plasma cells: do they indicate subclinical pelvic inflammatory disease?.  Sex Transm Dis. 2005;  32 185-188
• 35 Copperman A B, Wells V, Luna M, Kalir T, Sandler B, Mukherjee T. Presence of hydrosalpinx correlated to endometrial inflammatory response in vivo.  Fertil Steril. 2006;  86 972-976
• 36 Hill J A, Polgar K, Anderson D J. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion.  JAMA. 1995;  273 1933-1936
• 37 Ng S C, Gilman-Sachs A, Thaker P, Beaman K D, Beer A E, Kwak-Kim J. Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy.  Am J Reprod Immunol. 2002;  48 77-86
• 38 Ito C, Ito M, Itakura A, Asai M, Narita O, Mizutani S. A prospective evaluation of the effects of salpingectomy on endometrial lymphocyte clusters in patients with hydrosalpinges.  Fertil Steril. 2004;  82 149-153
• 39 Jinno M, Ozaki T, Iwashita M, Nakamura Y, Kudo A, Hirano H. Measurement of endometrial tissue blood flow: a novel way to assess uterine receptivity for implantation.  Fertil Steril. 2001;  76 1168-1174
• 40 Ng E H, Chan C C, Tang O S, Ho P C. Comparison of endometrial and subendometrial blood flows among patients with and without hydrosalpinx shown on scanning during in vitro fertilization treatment.  Fertil Steril. 2006;  85 333-338
• 41 Hehlgans S, Haase M, Cordes N. Signalling via integrins: implications for cell survival and anticancer strategies.  Biochim Biophys Acta. 2007;  175 163-180
• 42 Achache H, Revel A. Endometrial receptivity markers, the journey to successful embryo implantation.  Hum Reprod Update. 2006;  12 731-746
• 43 Lessey B A, Damjanovich L, Coutifaris C, Castelbaum A, Albelda S M, Buck C A. Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle.  J Clin Invest. 1992;  90 188-195
• 44 Lessey B A, Castelbaum A J, Wolf L et al.. Use of integrins to date the endometrium.  Fertil Steril. 2000;  73 779-787
• 45 Meyer W R, Castelbaum A J, Somkuti S et al.. Hydrosalpinges adversely affect markers of endometrial receptivity.  Hum Reprod. 1997;  12 1393-1398
• 46 Bildirici I, Bukulmez O, Ensari A, Yarali H, Gurgan T. A prospective evaluation of the effect of salpingectomy on endometrial receptivity in cases of women with communicating hydrosalpinges.  Hum Reprod. 2001;  16 2422-2426
• 47 Savaris R F, Pedrini J L, Flores R, Fabris G, Zettler C G. Expression of alpha 1 and beta 3 integrins subunits in the endometrium of patients with tubal phimosis or hydrosalpinx.  Fertil Steril. 2006;  85 188-192
• 48 Gearing D P. The leukemia inhibitory factor and its receptor.  Adv Immunol. 1993;  53 31-58
• 49 Hilton D J. LIF: lots of interesting functions.  Trends Biochem Sci. 1992;  17 72-76
• 50 Stewart C L, Kaspar P, Brunet L J et al.. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor.  Nature. 1992;  359 76-79
• 51 Charnock-Jones D S, Sharkey A M, Fenwick P, Smith S K. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time.  J Reprod Fertil. 1994;  101 421-426
• 52 Talbi S, Hamilton A E, Vo K C et al.. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women.  Endocrinology. 2006;  147 1097-1121
• 53 Laird S M, Tuckerman E M, Dalton C F, Dunphy B C, Li T C, Zhang X. The production of leukaemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture.  Hum Reprod. 1997;  12 569-574
• 54 Cohen M, Meisser A, Bischof P. Metalloproteinases and human placental invasiveness.  Placenta. 2006;  27 783-793
• 55 VanSaun M N, Matrisian L M. Matrix metalloproteinases and cellular motility in development and disease.  Birth Defects Res C Embryo Today. 2006;  78 69-79
• 56 Isaka K, Usuda S, Ito H et al.. Expression and activity of matrix metalloproteinase 2 and 9 in human trophoblasts.  Placenta. 2003;  24 53-64
• 57 Xu P, Wang Y L, Zhu S J, Luo S Y, Piao Y S, Zhuang L Z. Expression of matrix metalloproteinase-2, -9, and -14, tissue inhibitors of metalloproteinase-1, and matrix proteins in human placenta during the first trimester.  Biol Reprod. 2000;  62 988-994
• 58 Dong J C, Dong H, Campana A, Bischof P. Matrix metalloproteinases and their specific tissue inhibitors in menstruation.  Reproduction. 2002;  123 621-631
• 59 Salamonsen L A, Woolley D E. Matrix metalloproteinases in normal menstruation.  Hum Reprod. 1996;  11(suppl 2) 124-133
• 60 Jastrow N, Chardonnens D, Araman M, Meisser A, Campana A, Bischof P. Effect of hydrosalpinx fluid on secretion of trophoblastic matrix metalloproteinases.  Fertil Steril. 2002;  77 588-594
• 61 Daftary G S, Taylor H S. Endocrine regulation of HOX genes.  Endocr Rev. 2006;  27 331-355
• 62 Daftary G S, Taylor H S. Hydrosalpinx fluid diminishes endometrial cell HOXA10 expression.  Fertil Steril. 2002;  78 577-580
• 63 Daftary G S, Kayisli U, Seli E, Bukulmez O, Arici A, Taylor H S. Salpingectomy increases peri-implantation endometrial HOXA10 expression in women with hydrosalpinx.  Fertil Steril. 2007;  87 367-372
• 64 Kelekci S, Yilmaz B, Yakut Y, Yasar L, Savan K, Sonmez S. Hormonal and ovarian stromal blood supply changes after laparoscopic tubal sterilization: a prospective controlled study.  Contraception. 2006;  73 279-283
• 65 Baloglu A, Uysal D, Karci L, Guven C M, Yavuz E. Effects of laparoscopic tubal ligation on ovarian blood flow and steroidogenesis.  Clin Exp Obstet Gynecol. 2005;  32 230-232
• 66 Dede F S, Akyuz O, Dilbaz B, Caliskan E, Haberal A. Color Doppler flow analysis of uterine and ovarian arteries before and after tubal sterilization: electrocautery versus Pomeroy.  Gynecol Obstet Invest. 2006;  61 45-48
• 67 Kutlar I, Ozkur A, Balat O, Ugur M G, Genco Y, Aksoy F. Effects of three different sterilization methods on utero-ovarian Doppler blood flow and serum levels of ovarian hormones.  Eur J Obstet Gynecol Reprod Biol. 2005;  122 112-117
• 68 Kelekci S, Yilmaz B, Yasar L, Savan K, Sonmez S, Kart C. Ovarian reserve and ovarian stromal blood supply after tubal ligation by the Pomeroy technique: comparison with controls.  Gynecol Endocrinol. 2005;  20 279-283
• 69 Johnson N P, Mak W, Sowter M C. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.  Cochrane Database Syst Rev. 2004;  CD002125
• 70 Kontoravdis A, Makrakis E, Pantos K, Botsis D, Deligeoroglou E, Creatsas G. Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinx.  Fertil Steril. 2006;  86 1642-1649